Request Information  
iStock-1197479998
Press Release

NeuroVasc Enrolls First Patient in U.S. IDE Clinical Trial

NeuroVasc Technologies, Inc. announced that the first patient has been treated in its U.S. IDE Clinical Trial, ENVI RCT – NeuroVasc Envi™-SR Randomized Controlled Trial for Endovascular Treatment of Ischemic Stroke.
Read more   
iStock-1210446527
Press Release

NeuroVasc Enrolls First Patient in eNVi™-SR Clinical Trial in China

NeuroVasc Technologies, Inc. announced that the first patient has been treated in a Chinese Pivotal Randomized Controlled Trial to evaluate the safety and efficacy of the eNVi™-SR Mechanical Thrombectomy System (eNVi™-SR).
Read more   
placeholder-event
Press Release

NeuroVasc Secures $34M in Funding to Support Clinical Trials and Product Development

NeuroVasc Technologies, Inc. has entered into a strategic partnership with the Wego Group that includes $34 million in funding to support the company’s product portfolio development and global clinical trial program.
Read more